PHArmaCokinetics of methYLphenidate in Adult Patients With Attention-Deficit /Hyperactivity Disorder

NCT07121621 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder (ADHD)
Obesity (Body Mass Index &Amp;Amp;gt;30 kg/m2)
Methylphenidate
Obesity &Amp; Overweight

Interventions

DRUG: PHArmacoKinetics of methYLphenidate in adult patients with ADHD: comparison between patients with and without OBesity.

Sponsor

University Hospital, Tours

Collaborators

[object Object]